Hardeman E C, Jenke H S, Simoni R D
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1516-20. doi: 10.1073/pnas.80.6.1516.
We describe a cell line, designated C100, that displays a 100-fold increase in the major regulatory enzyme of the cholesterol biosynthetic pathway, 3-hydroxy-3-methylglutaryl-coenzyme A reductase [HMG-CoA; mevalonate:NADP(+) oxido-reductase (CoA-acylating), EC 1.1.1.34]. Immunoprecipitation of [(35)S]methionine-labeled enzyme from C100 microsomal membranes prepared in the presence of the protease inhibitors phenyl-methylsulfonyl fluoride and leupeptin revealed two up regulated proteins: a major band of M(r) 92,000 and a minor band of M(r) 63,000. We conclude that the M(r) 92,000 protein is probably the intact form of HMG-CoA reductase protomer based on the following criteria. (i) It is a highly up regulated microsomal membrane protein that coincides with the increase in HMG-CoA reductase specific activity in this cell line. (ii) It is recognized by a specific HMG-CoA reductase antiserum under a variety of stringencies. (iii) Isolation and solubilization of [(35)S]methionine-labeled C100 microsomal membranes in the absence of protease inhibitors resulted in the disappearance of the M(r) 92,000 protein and the appearance of two proteins of M(r) 52,000 and 38,000. (iv) Analysis of cells labeled for 30 min with [(35)S]methionine, well under the half-life of HMG-CoA reductase, revealed only the M(r) 92,000 protein to be present in total cell extract. (v) The previously reported single immunoprecipitation polypeptide for HMG-CoA reductase of M(r) 62,000 [Chin, D. J., Luskey, K. L., Anderson, R. G. W., Faust, J. R., Goldstein, J. L. & Brown, M. S. (1982) Proc. Natl. Acad. Sci. USA 79, 1185-1189] can be isolated and appears to be the result of both proteolysis and sample preparation for NaDodSO(4) gel electrophoresis. Analysis of C100 cells labeled with [(35)S]methionine for 24 hr indicates that the predominant steady-state form of the enzyme is the M(r) 92,000, rather than the M(r) 63,000, protein, further suggesting that the two proteins do not have a classical precursor-product relationship.
我们描述了一种命名为C100的细胞系,该细胞系中胆固醇生物合成途径的主要调节酶3-羟基-3-甲基戊二酰辅酶A还原酶[HMG-CoA;甲羟戊酸:NADP(+)氧化还原酶(辅酶A酰化),EC 1.1.1.34]的活性增加了100倍。在蛋白酶抑制剂苯甲基磺酰氟和亮肽素存在的情况下制备C100微粒体膜,并用[(35)S]甲硫氨酸标记酶进行免疫沉淀,结果显示有两种上调的蛋白质:一条主要条带的相对分子质量为92,000,一条次要条带的相对分子质量为63,000。基于以下标准,我们得出结论,相对分子质量为92,000的蛋白质可能是HMG-CoA还原酶单体的完整形式。(i)它是一种高度上调的微粒体膜蛋白,与该细胞系中HMG-CoA还原酶比活性的增加相一致。(ii)在多种严格条件下,它能被特异性的HMG-CoA还原酶抗血清识别。(iii)在不存在蛋白酶抑制剂的情况下,分离并溶解[(35)S]甲硫氨酸标记的C100微粒体膜,导致相对分子质量为92,000的蛋白质消失,出现相对分子质量为52,000和38,000的两种蛋白质。(iv)用[(35)S]甲硫氨酸标记细胞30分钟(远低于HMG-CoA还原酶的半衰期)后进行分析,结果显示总细胞提取物中仅存在相对分子质量为92,000的蛋白质。(v)先前报道的HMG-CoA还原酶的单一免疫沉淀多肽,其相对分子质量为62,000[Chin, D. J., Luskey, K. L., Anderson, R. G. W., Faust, J. R., Goldstein, J. L. & Brown, M. S. (1982) Proc. Natl. Acad. Sci. USA 79, 1185 - 1189],可以被分离出来,并且似乎是蛋白水解和用于十二烷基硫酸钠凝胶电泳的样品制备的结果。用[(35)S]甲硫氨酸标记C100细胞24小时后的分析表明,该酶的主要稳态形式是相对分子质量为92,000的蛋白质,而不是相对分子质量为63,000的蛋白质,这进一步表明这两种蛋白质不具有经典的前体-产物关系。